Monday, January 23, 2012 8:32:22 AM
By Seth Jayson | More Articles
January 11, 2012 |
Here at The Motley Fool, I've long cautioned investors to keep a close eye on inventory levels. It’s a part of my standard diligence when searching for the market's best stocks. I think a quarterly checkup can help you spot potential problems. For many companies, products that sit on the shelves too long can become big trouble. Stale inventory may be sold for lower prices, hurting profitability. In extreme cases, it may be written off completely and sent to the shredder.
Basic guidelines
In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Qiagen (Nasdaq: QGEN ) out of line? To figure that out, start by comparing the company’s inventory growth to sales growth. How is Qiagen doing by this quick checkup? At first glance, not so great. Trailing-12-month revenue increased 2.8%, and inventory increased 10.9%. Over the sequential quarterly period, the trend looks OK but not great. Revenue grew 2.4%, and inventory grew 4.4%.
Advanced inventory
I don’t stop my checkup there, because the type of inventory can matter even more than the overall quantity. There’s even one type of inventory bulge we sometimes like to see. You can check for it by examining the quarterly filings to evaluate the different kinds of inventory: raw materials, work-in-progress inventory, and finished goods. (Some companies report the first two types as a single category.)
A company ramping up for increased demand may increase raw materials and work-in-progress inventory at a faster rate when it expects robust future growth. As such, we might consider oversized growth in those categories to offer a clue to a brighter future, and a clue that most other investors will miss. We call it "positive inventory divergence.”
On the other hand, if we see a big increase in finished goods, that often means product isn’t moving as well as expected, and it’s time to hunker down with the filings and conference calls to find out why.
What’s going on with the inventory at Qiagen? I chart the details below for both quarterly and 12-month periods.
Source: S&P Capital IQ. Data is current as of latest fully-reported quarter. Dollar amounts in millions. FY = fiscal year. TTM = trailing 12 months.
Source: S&P Capital IQ. Data is current as of latest fully-reported quarter. Dollar amounts in millions. FQ = fiscal quarter.
Let's dig into the inventory specifics. On a trailing-12-month basis, work-in-progress inventory was the fastest-growing segment, up 16.9%. On a sequential-quarter basis, finished goods inventory was the fastest-growing segment, up 7.7%. That can be a warning sign, so investors should check in with Qiagen's filings to make sure there's a good reason for packing the storeroom for this period. Although Qiagen shows inventory growth that outpaces revenue growth, the company may also display positive inventory divergence, suggesting that management sees increased demand on the horizon.
Foolish bottom line
When you’re doing your research, remember that aggregate numbers such as inventory balances often mask situations that are more complex than they appear. Even the detailed numbers don’t give us the final word. When in doubt, listen to the conference call, or contact investor relations. What at first looks like a problem may actually signal a stock that will provide the market's best returns. And what might look hunky-dory at first glance could actually be warning you to cut your losses before the rest of the Street wises up.
I run these quick inventory checks every quarter. To stay on top of inventory and other tell-tale metrics at your favorite companies, add them to your free watchlist, and we’ll deliver our latest coverage right to your inbox.
http://www.fool.com/investing/general/2012/01/12/why-qiagen-may-be-about-to-take-off.aspx
Recent QGEN News
- QIAGEN to enhance the identification of human remains of Indigenous people and African Americans • GlobeNewswire Inc. • 07/08/2024 08:05:00 PM
- QIAGEN N.V. to release results for Q2 2024 and hold webcast • GlobeNewswire Inc. • 07/02/2024 01:29:56 PM
- QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children • GlobeNewswire Inc. • 06/27/2024 08:05:00 PM
- QIAGEN announces 2028 strategy for solid profitable growth • GlobeNewswire Inc. • 06/17/2024 11:30:00 AM
- QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs • GlobeNewswire Inc. • 06/13/2024 08:05:00 PM
- QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth • GlobeNewswire Inc. • 06/12/2024 08:05:00 PM
- QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance • GlobeNewswire Inc. • 06/11/2024 08:05:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/06/2024 08:50:44 PM
- QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period • GlobeNewswire Inc. • 06/06/2024 08:05:00 PM
- QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of its research platform GeneGlobe • GlobeNewswire Inc. • 06/05/2024 08:05:00 PM
- QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care • GlobeNewswire Inc. • 06/03/2024 06:00:00 AM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/31/2024 08:42:21 PM
- QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications • GlobeNewswire Inc. • 05/30/2024 09:55:30 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/30/2024 08:45:32 PM
- QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications • GlobeNewswire Inc. • 05/30/2024 08:05:00 PM
- QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine • GlobeNewswire Inc. • 05/29/2024 08:05:00 PM
- QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accurate results • GlobeNewswire Inc. • 05/13/2024 06:00:00 AM
- QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance • GlobeNewswire Inc. • 04/29/2024 08:05:00 PM
- QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance • GlobeNewswire Inc. • 04/24/2024 08:05:00 PM
- QIAGEN N.V. to release results for Q1 2024 and hold webcast • GlobeNewswire Inc. • 04/09/2024 01:48:45 PM
- QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024 • GlobeNewswire Inc. • 04/03/2024 08:05:00 PM
- QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system • GlobeNewswire Inc. • 03/25/2024 08:05:00 PM
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM